Table 2 Response to therapy and organ assessment
Cycles of chemotherapy | 6 |
|---|---|
Patients available for survival analysis | 36 |
Follow-up (mon) | 44 (31–59) |
EFS (mon) | 39.5 (12–59) |
Recurrence | 10 |
Death | 1 (death from disease progression) |
Response (available for response evaluation) | 36 |
 Better | 36 |
 Complete resolution (NAD) | 6 |
 Regressive disease | 30 |
Organ resolution | |
 Bone lesions (imaging evaluation) | 31 |
 CR | 12 |
 PR | 19 |
 Bone aching | 18 |
  Complete regression | 14 |
  Partial regression | 4 |
 CNS lesions (imaging evaluation) | 25 |
 CR | 13 |
 PR | 12 |